Immunic

(NASDAQ) IMUX

Current Price$14.94

Market Cap$203.91M

Since IPO (2019)-94%

5 Year-89%

1 Year+120%

1 Month+49%

Immunic Financials at a Glance

Market Cap

$203.91M

Revenue (TTM)

$0.00

Net Income (TTM)

-$104.29M

EPS (TTM)

-$6.03

P/E Ratio

-2.48

Dividend

$0.00

Beta (Volatility)

0.75 (Low)

Dividend

$0.00

Beta (Volatility)

0.75 (Low)

Price

$14.94

Volume

366,560.799

Open

$15.10

Price

$14.94

Volume

366,560.799

Open

$15.10

Previous Close

$14.96

Daily Range

$14.76 - $15.77

52-Week Range

$5.06 - $15.77

Dividend

$0.00

Beta (Volatility)

0.75 (Low)

Price

$14.94

Volume

366,560.799

Open

$15.10

Previous Close

$14.96

Daily Range

$14.76 - $15.77

52-Week Range

$5.06 - $15.77

IMUX News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Immunic

Industry

Biotechnology

Sector

Health Care

Employees

CEO

Daniel Vitt, PhD

Website

imux.com

Headquarters

New York City, NY 10036, US

IMUX Financials

Key Financial Metrics (TTM)

Gross Margin

Operating Margin

Net Income Margin

Return on Equity

-143%

Return on Capital

-72%

Return on Assets

-55%

Earnings Yield

-40.32%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$203.91M

Shares Outstanding

13.62M

Volume

366.56K

Avg. Volume

301.33K

Financials (TTM)

Gross Profit

$0.00

Operating Income

-$103.23M

EBITDA

-$103.06M

Operating Cash Flow

-$85.81M

Capital Expenditure

-$161.00K

Free Cash Flow

-$85.97M

Cash & ST Invst.

$15.48M

Total Debt

$684.00K

Immunic Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

$0.00

N/A

Gross Profit

-$33.00K

N/A

Gross Margin

0.00%

N/A

Market Cap

$203.91M

N/A

Market Cap/Employee

$2.24M

N/A

Employees

N/A

Net Income

-$32.59M

-27.9%

EBITDA

-$33.20M

-24.0%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Net Cash

$186.21M

+1297.0%

Accounts Receivable

$354.00K

-43.9%

Inventory

$0.00

N/A

Long Term Debt

$146.00K

-30.5%

Short Term Debt

$275.00K

-64.1%

Return on Assets

-54.96%

N/A

Return on Invested Capital

-72.43%

N/A

Free Cash Flow

-$17.30M

+20.7%

Operating Cash Flow

-$17.30M

+20.6%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

RPTXRepare Therapeutics Inc.

RPTXRepare Therapeutics Inc.$2.65+0.00%

ACETAdicet Bio, Inc.

ACETAdicet Bio, Inc.$9.31+7.75%

BMEABiomea Fusion, Inc.

BMEABiomea Fusion, Inc.$1.38+0.00%

TCRXTScan Therapeutics, Inc.

TCRXTScan Therapeutics, Inc.$1.08+0.00%

CBUSCibus, Inc.

CBUSCibus, Inc.$1.44-0.69%

PMVPPMV Pharmaceuticals, Inc.

PMVPPMV Pharmaceuticals, Inc.$1.20+0.84%

ACRVAcrivon Therapeutics, Inc. Common Stock

ACRVAcrivon Therapeutics, Inc. Common Stock$1.60-1.84%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

INTCIntel

INTCIntel$114.68-0.05%

FFord Motor Company

FFord Motor Company$17.44+0.05%

ONDSOndas

ONDSOndas$13.22-0.00%

NOKNokia

NOKNokia$14.84-0.03%

BBAIBigBear.ai

BBAIBigBear.ai$5.04+0.02%

PLTRPalantir Technologies

PLTRPalantir Technologies$156.54+0.09%

TAT&T

TAT&T$24.80-0.00%

Questions About IMUX

What is the current price of Immunic?

Immunic is trading at $14.96 per share.

What is the 52-week range for Immunic?

Over the past 52 weeks, Immunic has traded between $5.06 and $15.77.

How much debt does Immunic have?

As of the most recent reporting period, Immunic reported total debt of $421.00K.

How much cash does Immunic have on hand?

Immunic reported $186.63M in cash and cash equivalents in its most recent financial results.

What is Immunic’s dividend yield?

Immunic does not currently have a dividend yield.

Immunic

Immunic Financials at a Glance

IMUX News

Immunic (IMUX) Q2 Loss Widens 25%

Why Immunic Plummeted by 21% on Thursday

Why Immunic Stock Is Soaring Today

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Immunic

IMUX Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Immunic Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About IMUX

What is the current price of Immunic?

What is the 52-week range for Immunic?

How much debt does Immunic have?

How much cash does Immunic have on hand?

What is Immunic’s dividend yield?

Premium Investing Services